http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02067870-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78941ed5a01bfbcd48376e1fdb485b19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
filingDate 2002-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22dc3ccbcf422f142d0fadf64d1b1c60
publicationDate 2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02067870-A3
titleOfInvention Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
abstract The method for using matrix metalloproteinase ("MMP") inhibitors to prevent and treat Sinusoidal Obstruction Syndrome ("SOS"). In particular, the present invention provides a method of preventing and treating chemotherapy- and radiation-induced liver disease. This invention can be given prophylatically to patients who are receiving high dose chemotherapy and/or radiation and who are at risk for SOS or radiation-induced liver disease. This method may also be used to treat patients therapeutically who have developed SOS or radiation-induced liver disease. Because the development of chemotherapy or radiation-induced liver disease limits patient eligibility for several chemotherapeutic drugs, the present invention increases patient eligibility for many of these drugs.
priorityDate 2001-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6025353-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227160964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226526807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54740249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID466151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226488012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18650033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54671203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54686786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21117949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232257793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57272424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253

Total number of triples: 85.